Total Payments
$595.41
2024 Payments
$37.15
Companies
14
Transactions
33
Medicare Patients
1,594
Medicare Billing
$120,657
Payment Breakdown by Category
Food & Beverage$557.41 (93.6%)
Education$38.00 (6.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $557.41 | 32 | 93.6% |
| Education | $38.00 | 1 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Philips Electronics North America Corporation | $158.28 | 10 | $0 (2020) |
| GlaxoSmithKline, LLC. | $141.13 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $69.35 | 3 | $0 (2019) |
| Genentech USA, Inc. | $38.00 | 1 | $0 (2018) |
| Respiratory Technologies, Inc. | $25.00 | 1 | $0 (2017) |
| Allergan Inc. | $23.00 | 1 | $0 (2018) |
| Circassia Pharmaceuticals Inc | $21.05 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $20.54 | 1 | $0 (2017) |
| Shire North American Group Inc | $19.03 | 1 | $0 (2018) |
| Grifols USA, LLC | $18.17 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37.15 | 2 | GlaxoSmithKline, LLC. ($20.68) |
| 2020 | $14.05 | 1 | Philips Electronics North America Corporation ($14.05) |
| 2019 | $178.34 | 11 | Philips Electronics North America Corporation ($119.23) |
| 2018 | $227.45 | 12 | GlaxoSmithKline, LLC. ($54.75) |
| 2017 | $138.42 | 7 | GlaxoSmithKline, LLC. ($54.20) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: RESPIRATORY | ||||||
| 02/22/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Inflammation | ||||||
| 02/22/2020 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $14.05 | General |
| Category: Dental and Oral Health | ||||||
| 11/22/2019 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Pulmonology | ||||||
| 11/19/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $4.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $3.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $4.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $19.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $15.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/04/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $23.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/22/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $24.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/28/2019 | Philips Electronics North America Corporation | inCourage (Device) | Food and Beverage | Cash or cash equivalent | $23.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/14/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2018 | Shire North American Group Inc | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: RESPIRATORY | ||||||
| 07/30/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Respiratory | ||||||
| 07/24/2018 | Genentech USA, Inc. | Esbriet (Biological) | Education | In-kind items and services | $38.00 | General |
| Category: Immunology | ||||||
| 06/13/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: RESPIRATORY | ||||||
| 06/05/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/02/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: RESPIRATORY | ||||||
| 04/02/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 222 | 292 | $113,477 | $31,225 |
| 2022 | 10 | 513 | 592 | $145,878 | $35,537 |
| 2021 | 10 | 487 | 538 | $128,981 | $31,131 |
| 2020 | 9 | 372 | 428 | $97,679 | $22,764 |
Total Patients
1,594
Total Services
1,850
Medicare Billing
$120,657
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 31 | 48 | $34,366 | $8,097 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 76 | $23,672 | $6,543 | 27.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 43 | $20,338 | $6,178 | 30.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $12,614 | $3,819 | 30.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 23 | $11,198 | $2,885 | 25.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 38 | $7,613 | $2,368 | 31.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 28 | $3,056 | $1,127 | 36.9% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 14 | 14 | $620.00 | $208.60 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 113 | $31,075 | $10,731 | 34.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 24 | 50 | $35,500 | $8,710 | 24.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 32 | 32 | $16,864 | $5,650 | 33.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 58 | $15,370 | $4,796 | 31.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 19 | $9,766 | $3,085 | 31.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 93 | 93 | $8,649 | $835.01 | 9.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 98 | 98 | $14,602 | $734.27 | 5.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 97 | 97 | $12,125 | $644.13 | 5.3% |
| 94664 | Evaluation of use of breathing device | Office | 2022 | 21 | 21 | $882.00 | $276.54 | 31.4% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 11 | 11 | $1,045 | $74.17 | 7.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 82 | 98 | $26,950 | $9,635 | 35.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 39 | 39 | $20,553 | $6,575 | 32.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 15 | 37 | $26,270 | $6,298 | 24.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 21 | 21 | $10,794 | $3,391 | 31.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 32 | $8,480 | $2,617 | 30.9% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 86 | 86 | $7,932 | $826.11 | 10.4% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 94 | 94 | $13,886 | $757.82 | 5.5% |
About Dr. Emmanuel Tavan, MD
Dr. Emmanuel Tavan, MD is a Pulmonary Disease healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1003007907.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emmanuel Tavan, MD has received a total of $595.41 in payments from pharmaceutical and medical device companies, with $37.15 received in 2024. These payments were reported across 33 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($557.41).
As a Medicare-enrolled provider, Tavan has provided services to 1,594 Medicare beneficiaries, totaling 1,850 services with total Medicare billing of $120,657. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Portland, OR
- Active Since 08/06/2007
- Last Updated 06/24/2013
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1003007907
Products in Payments
- inCourage (Device) $119.23
- NUCALA (Biological) $78.83
- STIOLTO RESPIMAT (Drug) $39.91
- Esbriet (Biological) $38.00
- TRELEGY ELLIPTA (Drug) $32.18
- BREO (Drug) $30.12
- OFEV (Drug) $29.44
- Respiratoriy Care Undiv (Device) $25.00
- AVYCAZ (Drug) $23.00
- TUDORZA PRESSAIR (Drug) $21.05
- BEVESPI AEROSPHERE (Drug) $20.54
- GLASSIA (Biological) $19.03
- Prolastin-C Liquid (Biological) $18.17
- TEZSPIRE (Biological) $16.47
- LONHALA MAGNAIR (Drug) $15.84
- (8874) inCourage (Device) $14.05
- XARELTO (Drug) $11.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Portland
Jordan Fein, M.d, M.D
Pulmonary Disease — Payments: $69,409
Pulmonary Disease $69,409
Granthem Farr, Do, DO
Pulmonary Disease — Payments: $66,353
Pulmonary Disease $66,353
Melvin Morganroth, Md, MD
Pulmonary Disease — Payments: $23,131
Pulmonary Disease $23,131
Dr. Bishoy Zakhary, Md, MD
Pulmonary Disease — Payments: $10,967
Pulmonary Disease $10,967
Rick Balestra, M.d, M.D
Pulmonary Disease — Payments: $9,856
Pulmonary Disease $9,856
Vikram Sahni, M.d, M.D
Pulmonary Disease — Payments: $4,784
Pulmonary Disease $4,784